FIBROGAMMIN Powder and solvent for solution for injection Ref.[9446] Active ingredients: Coagulation factor XIII

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2018  Publisher: CSL Behring GmbH, Emil-von-Behring-Strasse 76, 35041, Marburg, Germany

Product name and form

Fibrogammin 250/1250 IU.

Powder and solvent for solution for injection or infusion.

Pharmaceutical Form

Powder and solvent for solution for injection/infusion.

White powder and clear, colourless solvent.

Qualitative and quantitative composition

Active substance: Fibrogammin is a purified concentrate of blood coagulation factor XIII (FXIII). It is derived from human plasma and is presented as a white powder.

Each vial contains nominally 250 or 1250 IU human plasma coagulation factor XIII.

Fibrogammin contains approximately 62.5 IU/ml (250 IU/4 ml or 1250/20 ml) of human plasma coagulation factor XIII when reconstituted with 4 ml or 20 ml water for injections, respectively.

The specific activity of Fibrogammin is approximately 3.1–13.3 IU/mg protein.

Excipients with known effect: Sodium (as chloride and hydroxide): 2.78 to 4.36 mg/ml (120 to 189 mmol/L)

For the full list of excipients, see section 6.1.

Active Ingredient Description
Coagulation factor XIII

Factor XIII connects the amino group of lysine with glutamine via its enzymatic function (transamidase activity), thereby leading to the cross-linking of fibrin molecules. This is the final stage of blood coagulation. Fibrin cross-linking and stabilisation promote the penetration of fibroblasts and support wound healing.

List of Excipients

Powder:

Human albumin
Glucose monohydrate
Sodium chloride*
Sodium hydroxide (for pH adjustment)

* see also section 4.4

Solvent:

Water for Injections

Pack sizes and marketing

Vials

250 IU:

Powder: injection vial of colourless glass, sealed with a bromobutyl rubber stopper, aluminium cap and plastic disc.

Solvent (Water for Injections): vial of colourless glass

1250 IU:

Powder: injection vial of colourless glass, sealed with a bromobutyl rubber stopper, aluminium cap and plastic disc.

Solvent (Water for Injections): vial of colourless glass.

Presentations

Pack with 250 IU:

1 vial with powder
1 vial with 4 ml Water for Injections
1 filter transfer device 20/20 (Mix2Vial)

Administration set (inner box):

1 disposable 5 ml syringe
1 venipuncture set
2 alcohol swabs
1 non-sterile plaster

Pack with 1250 IU:

1 vial with powder
1 vial with 20 ml Water for Injections
1 filter transfer device 20/20 (Mix2Vial)

Administration set (inner box):

1 disposable 20 ml syringe
1 venipuncture set
2 alcohol swabs
1 non-sterile plaster

Marketing authorization holder

CSL Behring GmbH, Emil-von-Behring-Strasse 76, 35041, Marburg, Germany

Marketing authorization dates and numbers

PL 15036/0006

22 June 1998 / 30 October 2003

Drugs

Drug Countries
FIBROGAMMIN Austria, Brazil, France, Israel, Japan, Lithuania, United Kingdom

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.